Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: Studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L)

European Cytokine Network

Volumn 12, Issue 2, 2001, Pages 231-238

  Bruserud, O ^a   Foss, B ^a   Petersen, H ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute leukemia; Chemotherapy; Flt3L; G CSF; GM CSF; IL 3

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; CEFTAZIDIME; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; IMIPENEM; INTERLEUKIN 3; METRONIDAZOLE; MITOXANTRONE; NETILMICIN; PENICILLIN G; TIOGUANINE; VANCOMYCIN;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BIOLOGICAL THERAPY; BLOOD LEVEL; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPENIA; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HUMAN CELL; LEUKOPENIA; MALE; MALIGNANT NEOPLASTIC DISEASE; NEUTROPENIA; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-3; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MEMBRANE PROTEINS; MIDDLE AGED; NEUTROPENIA;

BACTERIA (MICROORGANISMS);

EID: 0034982551     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Dissecting the marrow microenvironment
2. Hematopoiesis and angiogenesis: A link between two apparently independent processes
3. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor in the treatment of acute myeloid leukemia and acute lymphoblastic leukemia
4. Interleukin-3 in hematology and oncology: Current state of knowledge and future directions
5. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow
6. Effects of Flt3 ligand on acute myeloid and lymphoid leukemic blast cells from children
7. Acute myeloid leukemia
8. Acute myelogenous leukemia blasts as accessory cells during T lymphocyte activation: Possible implications for future therapeutic stategies
9. New strategies in the treatment of acute myelogenous leukemia: Mobilization and transplantation of autologous peripheral blood stem cells in adult patients
10. Induction of differentiation and apoptosis: A possible strategy in the treatment of acute myelogenous leukemia
11. Remission induction by granulocyte colony-stimulating factor in hypoplastic acute myelogenous leukemia complicated by infection. A case report and review of the literature
12. Unexpected remission of acute myelogenous leukemia after GM-CSF
13. Remission after erythropoietin administration for erythroleukemia: A case study
14. Successful treatment of a 93-year-old patient with hypoplastic acute monocytic leukemia using macrophage colony-stimulating factor
15. Granulocyte-macrophage colony-stimulating factor (GM-CSF), given concurrently with induction therapy for acute myelogenous leukemia (AML) augments the syndrome of T-lymphocyte recovery
16. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation
17. Studies of human platelet alpha-granule release in vivo
18. Acute lymphoblastic leukemia
19. Peripheral blood stem cell mobilization for high-dose chemotherapy
20. Serum levels of adhesion molecules and cytokines in patients with acute leukemia
21. Serum erythropoietin levels in patients with leukemia on cytostatic treatment
22. Inappropriate increase in erythropoietin titers during chemotherapy
23. Marked erythropoietin increase before fall in Hb after treatment with cytostatic drugs suggests mechanisms other than anaemia for stimulation
24. Endogenous haematopoietic growth factors in neutropenia and infection
25. Flow cytometric detection of growth factor receptors in autografts and analysis of growth factor concentrations in autologous stem cell transplantation: Possible significance for platelet recovery
26. Different pathways of human T cell activation revealed by PHA-P and PHA-M
27. Cytokine responsiveness of mitogen-activated T cells derived from acute leukemia patients with chemotherapy-induced leukopenia
28. Interleukin-4 responses in acute leukaemia patients with severe chemotherapy-induced leucopenia
29. Gene-marking to trace origin of relapse after autologous bone marrow transplantation